Cargando…
Longitudinal changes in glycated haemoglobin following treatment intensification after inadequate response to two oral antidiabetic agents in patients with type 2 diabetes
AIMS: To identify change in glycated haemoglobin (HbA1c) for 1 year after treatment intensification in patients with HbA1c >53 mmol/mol (7.0%) while on two classes of oral antidiabetic drugs (OADs). MATERIAL AND METHODS: A retrospective cohort study was conducted using a regional health plan clai...
Autores principales: | Kim, Kibum, Unni, Sudhir, Brixner, Diana I., Thomas, Sheila M., Olsen, Cody J., Sterling, Kimberly L., Mitchell, Matt, McAdam‐Marx, Carrie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618330/ https://www.ncbi.nlm.nih.gov/pubmed/30848039 http://dx.doi.org/10.1111/dom.13694 |
Ejemplares similares
-
Impact of Adherence and Weight Loss on Glycemic Control in Patients with Type 2 Diabetes: Cohort Analyses of Integrated Medical Record, Pharmacy Claims, and Patient-Reported Data
por: McAdam-Marx, Carrie, et al.
Publicado: (2014) -
Standardizing the haemoglobin glycation index
por: Hempe, James M., et al.
Publicado: (2021) -
d-Ribose as a Contributor to Glycated Haemoglobin
por: Chen, Xixi, et al.
Publicado: (2017) -
Efficacy of iGlarLixi in adults with type 2 diabetes inadequately controlled (glycated haemoglobin ≥8%, ≥64 mmol/mol) on two oral antidiabetes drugs: Post hoc analysis of the LixiLan‐O randomized trial
por: Davies, Melanie J., et al.
Publicado: (2021) -
Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy
por: Vilsbøll, Tina, et al.
Publicado: (2018)